ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	49/197	492/7206	4.2639049081e-16
ko04390	Hippo signaling pathway	28/197	188/7206	1.09421965809e-13
ko05217	Basal cell carcinoma	17/197	68/7206	1.76499476358e-12
ko04360	Axon guidance	27/197	233/7206	1.30529279828e-10
ko05224	Breast cancer	22/197	174/7206	1.46974796448e-09
ko04550	Signaling pathways regulating pluripotency of stem cells	20/197	165/7206	1.79203804249e-08
ko04916	Melanogenesis	17/197	142/7206	2.66996913879e-07
ko05205	Proteoglycans in cancer	24/197	271/7206	2.95226692708e-07
ko04391	Hippo signaling pathway - fly	13/197	90/7206	8.29951975504e-07
ko05222	Small cell lung cancer	12/197	89/7206	4.67521537381e-06
ko04151	PI3K-Akt signaling pathway	27/197	390/7206	6.57031207476e-06
ko04310	Wnt signaling pathway	17/197	181/7206	8.06889481444e-06
ko04340	Hedgehog signaling pathway	9/197	58/7206	2.37281543224e-05
ko04512	ECM-receptor interaction	10/197	79/7206	5.176543204e-05
ko04392	Hippo signaling pathway -multiple species	6/197	31/7206	0.000160928325383
ko04350	TGF-beta signaling pathway	10/197	103/7206	0.000480031609339
ko01522	Endocrine resistance	11/197	124/7206	0.000549687461056
ko04015	Rap1 signaling pathway	18/197	278/7206	0.000566772391541
ko04658	Th1 and Th2 cell differentiation	9/197	96/7206	0.0011811309716
ko05166	HTLV-I infection	18/197	292/7206	0.00126445643001
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/197	79/7206	0.00133939870378
ko04330	Notch signaling pathway	7/197	62/7206	0.00141221026261
ko05219	Bladder cancer	6/197	48/7206	0.00182375105552
ko05212	Pancreatic cancer	8/197	83/7206	0.00184537193683
ko04514	Cell adhesion molecules (CAMs)	10/197	130/7206	0.00286702555076
ko04011	MAPK signaling pathway - yeast	6/197	53/7206	0.00304772432158
ko05206	MicroRNAs in cancer	12/197	177/7206	0.00325135871538
ko04341	Hedgehog signaling pathway - fly	5/197	38/7206	0.00349801038014
ko04933	AGE-RAGE signaling pathway in diabetic complications	10/197	135/7206	0.00376805635804
ko04080	Neuroactive ligand-receptor interaction	3/197	423/7206	0.00499054050758
ko05146	Amoebiasis	8/197	99/7206	0.00553008806555
ko04919	Thyroid hormone signaling pathway	10/197	143/7206	0.00566282242385
ko04060	Cytokine-cytokine receptor interaction	12/197	191/7206	0.00598314351828
ko04510	Focal adhesion	14/197	240/7206	0.00708703285093
ko04670	Leukocyte transendothelial migration	10/197	151/7206	0.00823305875075
ko05220	Chronic myeloid leukemia	7/197	85/7206	0.0083755101497
ko00514	Other types of O-glycan biosynthesis	4/197	30/7206	0.00850846405986
ko05215	Prostate cancer	8/197	111/7206	0.010816155295
ko04530	Tight junction	13/197	228/7206	0.0111238046186
ko04722	Neurotrophin signaling pathway	10/197	160/7206	0.0121097684618
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/197	19/7206	0.0141179394836
ko04668	TNF signaling pathway	8/197	120/7206	0.0167410269157
ko04150	mTOR signaling pathway	11/197	184/7206	0.0175956005413
ko04810	Regulation of actin cytoskeleton	14/197	264/7206	0.0182173129617
ko04962	Vasopressin-regulated water reabsorption	5/197	58/7206	0.0206128601618
ko05145	Toxoplasmosis	8/197	126/7206	0.021810429591
ko04961	Endocrine and other factor-regulated calcium reabsorption	5/197	59/7206	0.0220375789377
ko04520	Adherens junction	7/197	103/7206	0.0223542249075
ko04014	Ras signaling pathway	14/197	279/7206	0.02383568813
ko05131	Shigellosis	6/197	82/7206	0.0242972887101
ko05142	Chagas disease (American trypanosomiasis)	8/197	130/7206	0.02574184252
ko00944	Flavone and flavonol biosynthesis	1/197	1/7206	0.0273383291702
ko05221	Acute myeloid leukemia	5/197	63/7206	0.0283703756109
ko01523	Antifolate resistance	3/197	30/7206	0.0475606357454